Bio Marketing
Why Asia Pacific Must Rethink Chronic Care Before the Demographic Tipping Point
Asia Pacific’s ageing economies are entering a more demanding phase of healthcare planning. As populations live longer, the challenge for healthcare ...
August 10, 2026 | Opinion | By Ambra Debernardi, Head of Employee Benefits and Corporate Relationships, APAC, Zurich Insurance
Laminar Pharma Completes Pivotal Phase 2b/3 Trial of LAM561 in Newly Diagnosed Glioblastoma
Laminar Pharma, a leader in the development of innovative therapies based on a novel membrane lipid therapy approach, announced that the last patient has c...
July 27, 2026 | News
Akeso Expands Immunology Franchise with Approval of Gumokimab for Psoriasis
Akeso, Inc. announced that the National Medical Products Administration (NMPA) of China has approved gumokimab (AK111), the company's internally-devel...
June 15, 2026 | News
SERB Pharmaceuticals Acquires European And MENA Rights To Idefirix From Hansa Biopharma
SERB Pharmaceuticals (“SERB”) and Hansa Biopharma AB (“Hansa”) (Nasdaq Stockholm: HNSA) announced that they have entered into an ag...
May 21, 2026 | News
Nona Biosciences Introduces New Global Brand Identity To Reflect Platform Driven Growth
Nona Biosciences, a global biotechnology company advancing biotherapeutic discovery through innovative technology platforms, announced the launch of i...
May 07, 2026 | News
Top GRC Platforms to Simplify Compliance Across Healthcare Systems
Across multiple locations, hundreds of staff members, and constantly shifting regulations, keeping everything documented, tracked, and audit-ready can feel...
April 07, 2026 | News
Thermo Fisher Scientific Opens 70,000 Sq Ft Distribution Center In Ireland To Expand Biopharma Supply Chain Capacity
70,000 sq. ft. facility expands the company’s biopharma, chemical and cold chain storage capacities Thermo Fisher Scientific Inc, the world leader i...
March 09, 2026 | News
Top 5 ABA Practice Management Software Compared: Features & Pricing (2026)
The ABA software market has grown considerably, and the range of options can make comparison difficult. Platforms vary widely in how they handle clinical d...
March 04, 2026 | News
8 Supplement Brands With Proven Health Benefits
Most people assume all supplements are created equal. They're not. While one brand might contain exactly what's on the label in bioavailable forms, another...
March 02, 2026 | News
Formosa Pharmaceuticals Signs Exclusive Licensing Agreement With Arrotex For APP13007 In Australia And New Zealand
Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced that the company has entered into an exclusive licensing agreement with Arrotex Ph...
February 24, 2026 | News
Hanmi Pharmaceutical Advances Global GLP 1 Strategy With Mexico Distribution Agreement For Efpeglenatide
Hanmi is accelerating its global market entry with efpeglenatide, Korea's first domestically developed GLP-1 class obesity and metabolic disease ...
January 29, 2026 | News
Novartis Secures Worldwide Licence To PepLib Peptide Asset To Expand Radioligand Therapy Pipeline
Zonsen PepLib Biotech Inc. announced that it has entered into a worldwide license agreement with Novartis for an undisclosed peptide-based asset in t...
January 15, 2026 | News
Nuclera Secures First Commercial Sales In Asia With Landmark Installations In Taiwan
Installations at National Taiwan University and National Cheng Kung University expand Nuclera’s global footprint with first commercial sales in Asi...
January 08, 2026 | News
TempraMed Technologies Ltd Expands South Korea Presence With New Commercial Order And Extended Distribution Partnership
TempraMed Technologies Ltd, a medical-technology innovator transforming how temperature-sensitive medications are stored and managed, is excited to announc...
January 05, 2026 | News
Most Read
- Can APAC Biomanufacturing Decarbonise Without Pricing Itself Out?
- The Algorithm on the GMP Floor: AI Promises a Smarter Plant. Regulators Demand the Audit Trail.
- APAC's Peptide-Capacity Gamble
- After the Rush: APAC's mRNA and Vaccine Capacity Hangover
- The Biosimilar Race: Factory to the World — or Stuck in the Copycat Economy?
- The Vein-to-Vein Problem: Can APAC's Cold Chain Carry Advanced Therapies?
- Vectors, Plasmids and the CGT Trap: APAC's Cell and Gene Therapy Ambitions Face an Upstream Bottleneck
- Can APAC Build Radioligand Therapy Before the Atoms Decay?
- The Great Biopharma Reset: 50 Developments That Changed Everything in H1 2026
- Beyond the Trial: Can Real-World Evidence Earn Regulatory Trust in APAC?
- Beyond the Obvious Giant: Where APAC's Clinical Trials Go Next
- The Frontier That Won’t Quite Arrive
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
